170918-29-3

Upstream product

• 101102-39-0 4,7-dimethylbenzimidazole 
• 860575-55-9 2-azido-1,4-dimethyl-3,5-dinitro-benzene 
• 77806-32-7 bromo-2 dinitro-3,5 p-xylene 
• 6311-52-0 3,6-dimethyl-2,4-dinitro-aniline 
• 64-18-6 formic acid 
• 101935-22-2 3,6-dimethyl-4-nitro-o-phenylenediamine 

Downstream Products

• 170918-30-6 5-amino-4,7-dimethylbenzimidazole 
• 170918-18-0 4,7-dimethyl-5-benzimidazolylisothiocyanate 

Relevant academic research and scientific papers

Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists

This invention involves compounds having the following structure: as described in the Claims; and enantiomers, optical isomers, stereoisomers, diastereomers, tautomers, addition salts, biohydrolyzable amides and esters thereof, as well as pharmaceutical compositions comprising such novel compounds. The invention also relates to the use of such compounds for preventing or treating disorders modulated by alpha-2 adrenoceptors.

5-(2-IMIDAZOLINYLAMINO)BENZIMIDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS

The subject invention involves compounds having the following structure: STR1 wherein: (a) R is unsubstituted C 1-C 3 alkanyl or alkenyl;(b) R' is selected from hydrogen; unsubstituted C 1-C 3 alkanyl or alkenyl; unsubstituted C 1-C 3 alkylthio or a

5-(2-IMIDAZOLINYLAMINO) BENZIMIDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS

The subject invention involves compounds having the following structure: STR1 wherein: (a) R is unsubstituted C 1-C 3 alkanyl or alkenyl;(b) R' is selected from hydrogen; unsubstituted C 1-C 3 alkanyl or alkenyl; unsubstituted C 1-C 3 alkylthio or a